- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-0855
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Identification of the natural product berberine as an antiviral drug ; volume:10 ; number:1 ; day:8 ; month:9 ; year:2020 ; pages:1-11 ; date:12.2020
AMB express ; 10, Heft 1 (8.9.2020), 1-11, 12.2020
- Creator
-
Shao, Jiping
Zeng, Debin
Tian, Shuhong
Liu, Gezhi
Fu, Jian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13568-020-01088-2
- URN
-
urn:nbn:de:101:1-2020102819411680741321
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shao, Jiping
- Zeng, Debin
- Tian, Shuhong
- Liu, Gezhi
- Fu, Jian
- SpringerLink (Online service)
Other Objects (12)
Antiviral activity of berberine
Antiviral drug strategies
Identification of berberine as a novel drug for the treatment of multiple myeloma via targeting UHRF1
Antiviral drugs against hepatitis C virus
A phenomics approach for antiviral drug discovery
The Antiviral Drug Arbidol Inhibits Zika Virus
Identification of FtfL as a novel target of berberine in intestinal bacteria
Repurpsing Antiviral Drugs for Orthogonal RNA-Catalyzed Labeling
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
Modelling the evolution of drug resistance in the presence of antiviral drugs
Antibacterial activity of a berberine nanoformulation
Antiviral activity of berberine
Antiviral drug strategies
Identification of berberine as a novel drug for the treatment of multiple myeloma via targeting UHRF1
Antiviral drugs against hepatitis C virus
A phenomics approach for antiviral drug discovery
The Antiviral Drug Arbidol Inhibits Zika Virus
Identification of FtfL as a novel target of berberine in intestinal bacteria
Repurpsing Antiviral Drugs for Orthogonal RNA-Catalyzed Labeling
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
Modelling the evolution of drug resistance in the presence of antiviral drugs
Antibacterial activity of a berberine nanoformulation
Antiviral activity of berberine
Antiviral drug strategies
Identification of berberine as a novel drug for the treatment of multiple myeloma via targeting UHRF1
Antiviral drugs against hepatitis C virus
A phenomics approach for antiviral drug discovery
The Antiviral Drug Arbidol Inhibits Zika Virus
Identification of FtfL as a novel target of berberine in intestinal bacteria
Repurpsing Antiviral Drugs for Orthogonal RNA-Catalyzed Labeling
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
Modelling the evolution of drug resistance in the presence of antiviral drugs